Molecular Biomarkers Predictive of Sertraline Treatment Response in Young Children With Autism Spectrum Disorder

AlOlaby, Reem Rafik; Jiraanont, Poonnada; Durbin‐Johnson, Blythe; Jasoliya, Mittal; Tang, Han; Hagerman, Randi J.; Tassone, Flora

doi:10.3389/fgene.2020.00308

Search citation statements

Order By: Relevance

Paper Sections

Select...

Leslie L Citrome Md Mph Editor1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

2024

Publication Types

Select...

Article3

Book2

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 5 publications

(1 citation statement)

References 94 publications

(104 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…studying the effects of SSRIs (2006 and 2013) 10,11 indicated marked variability in clinical response (for repetitive, restricted behaviors and interests, or RRBIs) 12 ranging from no effects, 13,14 to increased likelihood of behavioral activation, 3,15 to the potential for harm. 16 Second, the 2023 epidemiological trends suggest an increase in the prevalence (1:36 under the age of 8) attributed to many factors including late or missed diagnosis.…”

Section: Leslie L Citrome Md Mph Editormentioning

confidence: 99%